Fas receptor is expressed in human lung squamous cell carcinomas, whereas bcl-2 and apoptosis are not pronounced: A preliminary report

British Journal of Cancer

Volumn 76, Issue 2, 1997, Pages 175-179

  Hellquist, H B ^a,b   Olejnicka, B ^a   Jadner, M ^a   Andersson, T ^a   Sederholm, C ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Apoptosis; Bcl 2; Cd95; Fas; Immunocytochemistry; In situ hybridization; Lung cancer

Indexed keywords

CELL RECEPTOR; FAS ANTIGEN; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; BRONCHUS MUCOSA; CELL SELECTION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LUNG SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION;

EID: 0031011301     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.359     Document Type: Article

References (34)

1. Aggarwal BB, Singh S, Lapushin R and Totpal K (1995) Fas antigen signals proliferation of normal human diploid fibroblast and its mechanism is different from tumor necrosis factor receptor. FEBS 363: 5-8
2. Arends MJ, McGregor AH and Wyllie AH (1994) Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed mye, ras and HPV oncogenes. Am J Pathol 144: 1145-1057
3. Berenson JR, Koga H, Yang J, Pearl J, Holmes C, Figlin R and the Lung Cancer Study Group (1990) Frequent amplification of the bel-1 locus in poorly differentiated squamous cell carcinoma. Oncogene 5: 1343-1348
4. Cerroni L and Kerl H (1944) Aberrant bel-2 protein expression provides a possible mechanism of neoplastic cell growth in cutaneous basal-cell carcinoma. J Cutan pathol 21: 398-403
5. Dewey WC, Ling CC and Meyn RE (1995) Radiation-induced apoptosis: relevance to radiotherapy Int J Radiat Oncol Biol Phys 33: 781-796
6. Doglioni C, Dei Tos AP, Laurino L, Chiarelli C, Barbareschi M and Viale G (1994) The prevalence of BCL-2 immunoreactivily in breast carcinomas and its clinieopathological correlates, with particular reference to oestrogen receptor status. Virchows Arch 424: 47-51
7. Dole M, Nunez G, Merchant AK, Maybaum J, Rode CK, Bloch CA and Castle VP (1494) Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res 54: 3253-3259
8. Faber LP (1991) Lung cancer. In American Cancer Society Texbook of Clinical Oncology, Holleb AI, Fink DJ and Murphy GP. (eds), pp. 194-212. The American Cancer Society: Atlanta
9. Firestein GS, Yeo M and Zvaifler NJ (1995) Apoptosis in rheumatoid arthritis synovium. J Clin Invest 96: 1631-1638
10. Gavrieli Y, Sherman Y and Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear fragmentation. J Cell Biol 119: 493-501
11. Gulhins E, Bissonnette R, Mahboubi A, Martin S, Nishioka W, Brunner T, Baier G, Baier-Bitterlich G, Byrd C, Lang F, Kolesnick R, Altman A and Green D (1995) FAS-incluced apoptosis is mediated via a ceramide-initiated RAS signaling pathway, Immunity 2: 1-2
12. Hashimoto H, Chatterjee S and Berger NA (1995) Inhibition of Klopside (VP-16)-induced DNA recombination and mutant frequency by Bcl-2 protein overexpression. Cancer Res 55: 4029-4035
13. Ijiri K and Potten CS (1983) Response of intestinal cells of differing topographical and hierarchical status to ten cytotoxic drugs and five sources of radiation. Br J Cancer 47: 175-185
14. Itoh N and Nagata S (1993) A novel protein domain required for apoptosis. J Biol Chem 268: 10932-10937
15. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S-J, Sameshima M, Hase A, Seto Y and Nagata S (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66: 233-243
16. Koizumi H, Wakisaka M, Nakada K, Takakuwa T, Fujioka T, Yamate N and Uchikoshi T (1995) Demonstration of apoptosis in neuroblastoma and its relationship to tumour regression. Virchows Arch 427: 167-173
17. Ling CC, Chen CH and Fuks Z (1994) An equation for the dose responce of radiation-induced apoptosis: possible incorporation with the LQ model. Radiother Oncol 33: 17-22
18. Meyn RE, Stephens LC, Ang KK, Hunter NR, Brock WA, Milas L and Peters LJ (1993) Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies. Int J Radiat Biol 64: 583-591
19. Moreira LF, Naomoto Y, Hamada M, Kamikawa Y and Onto K (1995) Assessment of apoptosis in oesophageal carcinoma preoperatively treated by chemotherapy and radiotherapy. Anticancer Res 15: 639-644
20. Nunez G, London L, Hockenbery D, Alexander M, McKearn JP and Korsmeyer SJ (1990) Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 144: 3602-3610
21. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T and Nagata S (1993) Lethal effect of the anti-Fas antibody in mice. Nature 364: 806-809
22. Pezzella F, Turley H, Kuzu I, Tungekar MF, Dunnill MS, Pierce CB, Harris A, Gatter KC and Mason DY (1993) bel-2 protein in non-small-cell lung carcinoma. N Engl J Med 329: 690-694
23. Pilotti S, Collini S, Rilke F, Cattoretti G, Del Bo R and Pierotti MA (1994) BCL-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland. J Pathol 172: 337-342
24. Ritter JH, Dresler JH and Wick MR (1995) Expression of bcl-2 in stage T1N0M0 non-small cell lung carcinoma. Hum Pathol 26: 1227-1232
25. Rouvier E, Louvier E, Luciani MF and Goldstein P (1993) Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity. J Exp Med 177: 195-200
26. Shi S-R, Key ME and Kalra KL (1991) Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39: 741-748
27. Sleater JP, Beers BB, Stephens CA and Hendricks JB (1994) Keratoacanthoma: a deficient squamous cell carcinoma? Study of bcl-2 expression. J Cutan Pathol 21: 514-519
28. Stapper NJ, Stuschke M, Sak A and Stube G (1995) Radiation-induced apoptosis in human sarcoma and glioma cell lines. Int J Cancer 62: 58-62
29. Törmänen U, Eerola A-K, Rainio P, Vähäkangas K, Soini Y, Sormunen R, Bloigu R, Lehto V-P and Pääkkö P (1995) Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma. Cancer Res 55: 5595-5602
30. Trauth BC, Klas C, Peters AMJ, Matzku S, Möller P, Falk W, Debatin K-M and Krammer PH (1989) Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245: 301-305
31. Uehara T, Kuwashima Y, Izumo T, Kishi K, Shiromizu K and Matsuzawa M (1995) Expression of the proto-oncogene bcl-2 in uterine cervical squamous cell carcinoma: its relationship to clinical outcome. Eur J Gynaecol Oncol 16: 453-460
32. Vaux DL, Cory S and Adams JM (1988) Bcl-2 gene promotes haematopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335: 440-445
33. Wyllie AH (1985) The biology of cell death in tumors. Anticancer Res 5: 131-136
34. Yonehara S, Ishii A and Yonehara A (1989) A cell-killing monoclonal antibody (anti-fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169: 1747-1756